JWH-307

JWH-307

Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible) US: Schedule I
Identifiers
IUPAC name (5-(2-Fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone
CAS Number	914458-26-7 Y
PubChem CID	16049783
ChemSpider	13178178
UNII	06QTR14ONW
CompTox Dashboard (EPA)	DTXSID60581542
Chemical and physical data
Formula	C26H24FNO
Molar mass	385.482 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCCN1C=C(C=C1C2=CC=CC=C2F)C(=O)C3=CC=CC4=CC=CC=C43
InChI InChI=1S/C26H24FNO/c1-2-3-8-16-28-18-20(17-25(28)23-13-6-7-15-24(23)27)26(29)22-14-9-11-19-10-4-5-12-21(19)22/h4-7,9-15,17-18H,2-3,8,16H2,1H3 Key:WYNZPDDTQGVCLZ-UHFFFAOYSA-N
(verify)

JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB₁ and CB₂ receptors. It is somewhat selective for the CB₂ subtype, with a K_i of 7.7 nM at CB₁ vs 3.3 nM at CB₂. It was discovered by, and named after, John W. Huffman. JWH-307 was detected as an ingredient in synthetic cannabis smoking blends in 2012, initially in Germany.

In the United States, CB₁ receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-307 are Schedule I Controlled Substances.

See also

• JWH-147